Escitalopram oxalate. Antidepressant, 5-HT reuptake inhibitor

Drugs of the Future

Volumn 26, Issue 2, 2001, Pages 115-120

  Sorbera, L A ^a   Revel, L ^a   Martin L ^a   Castaner J ^a  

^a PROUS SCIENCE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; CITALOPRAM; ESCITALOPRAM; FLUVOXAMINE; SEROTONIN UPTAKE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG SYNTHESIS; DRUG TRANSPORT; ENANTIOMER; HUMAN; NAUSEA; NONHUMAN; TREMOR;

EID: 0035055653     PISSN: 03778282     EISSN: None     Source Type: Journal    
DOI: 10.1358/dof.2001.026.02.610572     Document Type: Article

References (27)

1. Global survey examines impact of depression
2. Safety and tolerability considerations: Tricyclic antidepressants vs. selective serotonin reuptake inhibitors
3. The S-enantiomer of citalopram (LU 26-054) is a highly selective and potent serotonin reuptake inhibitor
4. The antidepressant effects of citalopram are mediated by the S-(+)- and not the R(-)-enantiomer
5. The pharmacological effect of citalopram resides in the (S)-(+)-enantiomer
6. The next generation SSRIs: A comparison of the transporter binding profile of R-fluoxetine and S-citalopram (LU 26-054)
7. Transport mechanisms for the antidepressant citalopram in brain microvessel endothelium
8. Fluorescence assay of citalopram and its metabolites in plasma by scanning densitometry of thin-layer chromatograms
9. High-performance liquid chromatographic determination of citalopram and four of its metabolites in plasma and urine samples from psychiatric patients
10. Determination of citalopram enantiomers in human plasma by liquid chromatographic separation on a chiral-AGP column
11. Determination of the enantiomers of citalopram, its demethylated and propionic acid metabolites in human plasma by chiral HPLC
12. Analysis of enantiomers of citalopram and its demethylated metabolites in plasma of depressive patients using chiral reverse-phase liquid chromatography
13. Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography
14. Stereoselective HPLC-assay for citalopram and its metabolites
15. Studies on the stereoselective metabolism of citalopram by human liver microsomes and cDNA-expressed cytochrome P450 enzymes
16. Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes
17. Stereoselective biotransformation of the selective serotonin reuptake inhibitor citalopram and its demethylated metabolites by monoamine oxidases in human liver
18. Escitalopram metabolism in vitro
19. Neuroendocrine effects of a 20-mg citalopram infusion in healthy males. A placebo-controlled evaluation of citalopram as 5-HT function probe
20. Steady-state pharmacokinetics of the enantiomers of citalopram and its metabolites in humans
21. Plasma levels of citalopram enantiomers and metabolites in elderly patients
22. Non-response to citalopram in depressive patients: Pharmacokinetic and clinical consequences of a fluvoxamine augmentation